Autoplaque vs cV8 Diagnostic Ultrasound System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Autoplaque

by APQ Health (formerly Cedars-Sinai Medical Center: AIM)

cV8 Diagnostic Ultrasound System

by Samsung Medison Co.

AI Verdict

These tools are adjacent in their application of AI to cardiology and radiology, but they serve distinct purposes. Autoplaque specializes in post-processing CT angiography images for quantitative coronary plaque analysis, aiding in heart attack risk prediction. In contrast, the Samsung cV8 is a diagnostic ultrasound system that uses AI to enhance real-time image acquisition and provide diagnostic assistance across various specialties, including fetal heart diagnosis, rather than analyzing existing CT scans.

Choose Autoplaque if…

Choose Autoplaque if your primary need is detailed, AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. This workstation-based software is ideal for cardiologists and radiologists seeking to precisely characterize atherosclerotic plaque, measure vessel dimensions, and aid in heart attack risk prediction and treatment guidance based on CT data.

View Autoplaque →

Choose cV8 Diagnostic Ultrasound System if…

Choose the Samsung Medison cV8 Diagnostic Ultrasound System if you require a versatile, mobile, and AI-assisted ultrasound solution for a broad range of diagnostic applications beyond just cardiology, including obstetrics, gynecology, and neurology. This system is best suited for clinicians who need superior image quality and intelligent assist tools for real-time imaging, diverse anatomical assessments, and streamlined workflow efficiency across multiple specialties.

View cV8 Diagnostic Ultrasound System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Autoplaque	cV8 Diagnostic Ultrasound System
Pricing	Unknown	Contact vendor
Deployment	Workstation-based post-processing application, runs on Windows or Mac OS.	On-premise (hardware)
FDA Status	1 AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Autoplaque is a workstation-based software designed for trained medical professionals, offering automated segmentation that is reviewable and editable. The Samsung cV8 is a mobile ultrasound system with an ergonomic design, a dedicated cardiovascular control panel, and AI-based intelligent assist solutions aimed at enhancing workflow efficiency. Both tools emphasize user-friendly interfaces and features to streamline clinical tasks, making it difficult to definitively declare one superior in usability without direct user feedback or comparative studies.

Clinical Value

Autoplaque

Autoplaque provides quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, directly aiding in heart attack risk prediction and treatment guidance, with clinical validation studies demonstrating excellent agreement with expert reader measurements. The cV8 Diagnostic Ultrasound System offers advanced imaging and AI-based assistance for various specialties, including cardiac diagnosis, but its direct impact on specific clinical outcomes like heart attack risk prediction is less explicitly stated compared to Autoplaque's focused application.

Pricing & Value

Tie

Neither Autoplaque nor the Samsung cV8 Diagnostic Ultrasound System have publicly disclosed pricing information, making a direct comparison of their value propositions challenging. Both require contacting the vendor for pricing details.

Enterprise Readiness

cV8 Diagnostic Ultrasound System

The Samsung cV8 Diagnostic Ultrasound System is a mobile, on-premise hardware solution with a BAA and HIPAA compliance explicitly stated, indicating its readiness for enterprise deployment and data security. Autoplaque is workstation-based software, but its BAA and HIPAA compliance are not specified, which could be a barrier for enterprise adoption in healthcare settings with strict compliance requirements.

Innovation

cV8 Diagnostic Ultrasound System

The Samsung cV8 Diagnostic Ultrasound System showcases broader innovation with its Crystal Architectureu2122 for superior image quality and a wider range of AI-based intelligent assist solutions like NerveTracku2122 and HeartAssistu2122 across diverse medical specialties. While Autoplaque offers innovative AI-powered quantitative analysis for coronary plaques, the cV8's comprehensive suite of advanced imaging and AI tools for multiple applications suggests a broader scope of innovation.

Support & Docs

Tie

Neither the provided structured facts nor web searches offered specific details regarding the level of ongoing support, training, or documentation available for either Autoplaque or the Samsung cV8 Diagnostic Ultrasound System. Without this information, it is not possible to determine a winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Autoplaque	cV8 Diagnostic Ultrasound System
Name	Autoplaque	cV8 Diagnostic Ultrasound System
Company	Cedars-Sinai Medical Center: AIM	Samsung Medison Co.
Description	Autoplaque, developed by Cedars-Sinai AIM, is an FDA-cleared AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance.	The Samsung Medison cV8 Diagnostic Ultrasound System is a premium, mobile, and software-controlled ultrasound system featuring advanced Crystal Architectureu2122 for superior image quality and AI-based diagnostic assistance tools like NerveTracku2122 and HeartAssistu2122 to enhance clinical confidence and workflow efficiency across diverse medical specialties.
Categories	Cardiology AI, Radiology & Imaging AI	Cardiology AI, Radiology & Imaging AI
Specialties	Cardiology, Radiology	Neurology, Obstetrics & Gynecology, Radiology
Key Features (AI/Imaging)	AI-powered quantitative analysis of atherosclerotic plaque; Detection and characterization of coronary artery plaque; Measurement of luminal stenoses; Automated vessel, plaque, and lumen segmentation (reviewable and editable by clinician)	Crystal Architectureu2122 (CrystalBeamu2122, CrystalLiveu2122, S-Vue Single Crystal Transducersu2122) for superior image clarity and penetration; AI-based Intelligent Assist solutions: NerveTracku2122 (nerve detection), UterineAssistu2122 (uterus measurement), BiometryAssistu2122 (fetal growth), ViewAssistu2122 (fetal annotation), HeartAssistu2122 (fetal heart diagnosis); MV-Flowu2122 and LumiFlowu2122 for detailed microvascular blood flow visualization; S-Shearwave Imagingu2122 for quantitative tissue stiffness assessment; S-Fusionu2122 technology for synchronous alignment of ultrasound with other imaging modalities like MRI; ShadowHDRu2122 for suppressing shadows and enhancing grayscale image clarity

Videos

Demos, reviews, and walkthroughs featuring Autoplaque and cV8 Diagnostic Ultrasound System.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems?

Autoplaque is a workstation-based post-processing application designed for cardiologists and radiologists to analyze cardiac CT data. It allows for automated vessel, plaque, and lumen segmentation, which clinicians can review and edit. The cV8 Diagnostic Ultrasound System is a mobile, hardware-based ultrasound system with AI-based intelligent assist solutions to enhance workflow efficiency across diverse medical specialties. While Autoplaque focuses on post-processing CT angiography images, the cV8 integrates into real-time ultrasound examinations.

What is the accuracy and sensitivity of each tool's AI-powered analysis?

Autoplaque has demonstrated excellent correlation with intravascular ultrasound (IVUS) for quantifying noncalcified plaque volumes (r = 0.94, P < .001) and calcified plaque volumes. It can quantify plaque as accurately as trained doctors, but in seconds rather than 25-30 minutes per scan. The cV8 Diagnostic Ultrasound System leverages advanced Crystal Architectureu2122 for superior image clarity and penetration, and includes AI-based tools like NerveTracku2122 and HeartAssistu2122 to enhance diagnostic confidence. AI-assisted focused cardiac ultrasound has shown high diagnostic accuracy, with one study reporting 94.33% accuracy, 89.91% sensitivity, and 96.49% specificity.

Which medical specialties are these tools best suited for, and what specific clinical problems do they address?

Autoplaque is specifically designed for cardiology and radiology, aiding in heart attack risk prediction and treatment guidance by providing quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. The cV8 Diagnostic Ultrasound System is a versatile tool suitable for neurology, obstetrics & gynecology, and radiology, offering AI-based assistance for nerve detection (NerveTracku2122), uterus measurement (UterineAssistu2122), fetal growth (BiometryAssistu2122), fetal annotation (ViewAssistu2122), and fetal heart diagnosis (HeartAssistu2122).

What is the typical learning curve for physicians and technical staff using these tools?

Autoplaque is a workstation-based application intended for use by trained medical professionals, including radiologists and cardiologists, who have been appropriately trained in its functions. The automated vessel, plaque, and lumen segmentation can be reviewed and edited by the clinician, suggesting a degree of user interaction. The cV8 Diagnostic Ultrasound System features an ergonomic design and intelligent assist solutions aimed at streamlining examination protocols and workflow efficiency, which can contribute to an easier learning curve. AI-powered ultrasound systems, in general, are designed to help clinicians of varying experience levels acquire quality diagnostic images and automate image interpretation.

What audit trail features are available to ensure data integrity and support clinical review?

Autoplaque provides automated vessel, plaque, and lumen segmentation that is reviewable and editable by the clinician, implying a mechanism for oversight and potential record of changes. While specific audit trail features are not detailed, the ability to review and edit suggests a level of accountability. For the cV8 Diagnostic Ultrasound System, the information provided does not explicitly detail audit trail features. However, modern diagnostic systems typically include features for data management and record-keeping to support clinical review and regulatory requirements.

How do these tools support multi-site rollout and data consistency across different locations?

Autoplaque is a workstation-based software that runs on Windows or Mac platforms, making it deployable across various sites with compatible computer systems. The consistency of results would depend on standardized CT angiography protocols and user training across sites. The cV8 Diagnostic Ultrasound System is a mobile, on-premise hardware solution, meaning each site would require its own system. Its AI-based features aim to reduce inter-operator variability and improve consistency in image acquisition and analysis, which could aid in multi-site data consistency.